LPCUF (Lee's Pharmaceutical Holdings) Net Margin % : 9.49% (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Lee's Pharmaceutical Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Lee's Pharmaceutical Holdings's Net Income for the six months ended in Jun. 2024 was $8.0 Mil. Lee's Pharmaceutical Holdings's Revenue for the six months ended in Jun. 2024 was $84.3 Mil. Therefore, Lee's Pharmaceutical Holdings's net margin for the quarter that ended in Jun. 2024 was 9.49%.

The historical rank and industry rank for Lee's Pharmaceutical Holdings's Net Margin % or its related term are showing as below:

LPCUF' s Net Margin % Range Over the Past 10 Years
Min: 1.59 Med: 21.63 Max: 156.95
Current: 6.65

LPCUF's Net Margin % is ranked better than
56.98% of 974 companies
in the Drug Manufacturers industry
Industry Median: 4.585 vs LPCUF: 6.65

Lee's Pharmaceutical Holdings Net Margin % Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Net Margin % Chart

Lee's Pharmaceutical Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Margin %

Get a 7-Day Free Trial

10.63

156.95

4.16

1.59

6.65

Lee's Pharmaceutical Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Margin %	Get a 7-Day Free Trial															3.91	3.15	0.11	9.49	4.13

Competitive Comparison of Lee's Pharmaceutical Holdings's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lee's Pharmaceutical Holdings's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's Net Margin % falls into.

Save Embed

;

Save Embed

;

Lee's Pharmaceutical Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Lee's Pharmaceutical Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	2.138	/	134.835
	=	1.59 %

Lee's Pharmaceutical Holdings's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	8	/	84.295
	=	9.49 %

Lee's Pharmaceutical Holdings (OTCPK:LPCUF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Lee's Pharmaceutical Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lee's Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (OTCPK:LPCUF) » Definitions » Net Margin %

Traded in Other Exchanges

00950:Hong Kong

Address

Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG

Website

https://www.leespharm.com

Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines